scispace - formally typeset
Y

Yolanda De Diego Otero

Researcher at Erasmus University Rotterdam

Publications -  5
Citations -  479

Yolanda De Diego Otero is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: FMR1 & Fragile X syndrome. The author has an hindex of 5, co-authored 5 publications receiving 467 citations.

Papers
More filters
Journal ArticleDOI

Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse.

TL;DR: The colocalization of the Fxr proteins in neurons is consistent with similar cellular functions in those specific cells, and the presence of the three proteins in the nucleus of hippocampal neurons suggests a nucleocytoplasmic shuttling for the FXr proteins.
Journal ArticleDOI

Transport of fragile X mental retardation protein via granules in neurites of PC12 cells.

TL;DR: This report is the first example of trafficking of RNA-containing granules with FMRP as a core constituent in living PC12 cells and shows that the movement of F MRP-GFP labeled granules into the neurites was microtubule dependent.
Journal ArticleDOI

Noninvasive test for fragile X syndrome, using hair root analysis.

TL;DR: A new diagnostic test to identify male patients with fragile X syndrome, on the basis of lack of FMRP in their hair roots, is described, which enabled us to identify two fragile X patients who did not show the full mutation by analysis of DNA isolated from blood cells.
Journal ArticleDOI

Twin sisters, monozygotic with the fragile X mutation, but with a different phenotype

TL;DR: In this article, the absence of the fragile X mental retardation protein (FMRP) results in fragile X syndrome, where all males with a full mutation in the FMR1 gene and an inactive FMR 1 gene are mentally retarded while 60% of the females with full mutation are affected.
Journal ArticleDOI

Immunocytochemical characterization of FMRP, FXR1P and FXR2P during embryonic development in the mouse

TL;DR: This descriptive study has performed immunolocalization of these proteins during the embryonic development of the mouse to get more insight in their physiological function and the results are discussed in relation to the pathogenesis of the fragile X syndrome.